Annual EBIT
-$21.14 M
-$2.43 M-12.99%
December 31, 2023
Summary
- As of February 7, 2025, NSPR annual earnings before interest & taxes is -$21.14 million, with the most recent change of -$2.43 million (-12.99%) on December 31, 2023.
- During the last 3 years, NSPR annual EBIT has fallen by -$10.76 million (-103.69%).
- NSPR annual EBIT is now -556294.74% below its all-time high of -$3800.00, reached on June 30, 2009.
Performance
NSPR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$8.46 M
-$202.00 K-2.45%
September 30, 2024
Summary
- As of February 7, 2025, NSPR quarterly earnings before interest & taxes is -$8.46 million, with the most recent change of -$202.00 thousand (-2.45%) on September 30, 2024.
- Over the past year, NSPR quarterly EBIT has dropped by -$2.82 million (-50.06%).
- NSPR quarterly EBIT is now -128312.12% below its all-time high of $6600.00, reached on September 30, 2009.
Performance
NSPR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$29.94 M
-$2.82 M-10.41%
September 30, 2024
Summary
- As of February 7, 2025, NSPR TTM earnings before interest & taxes is -$29.94 million, with the most recent change of -$2.82 million (-10.41%) on September 30, 2024.
- Over the past year, NSPR TTM EBIT has dropped by -$9.67 million (-47.72%).
- NSPR TTM EBIT is now -475401.59% below its all-time high of $6300.00, reached on September 30, 2009.
Performance
NSPR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NSPR EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -13.0% | -50.1% | -47.7% |
3 y3 years | -103.7% | -109.9% | -106.5% |
5 y5 years | -177.8% | -245.9% | -233.8% |
NSPR EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -43.7% | at low | -115.3% | at low | -103.5% | at low |
5 y | 5-year | -115.4% | at low | -318.7% | at low | -243.9% | at low |
alltime | all time | <-9999.0% | +15.4% | <-9999.0% | +40.1% | <-9999.0% | at low |
InspireMD EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$8.46 M(+2.4%) | -$29.94 M(+10.4%) |
Jun 2024 | - | -$8.26 M(+11.4%) | -$27.12 M(+12.2%) |
Mar 2024 | - | -$7.41 M(+27.7%) | -$24.18 M(+14.3%) |
Dec 2023 | -$21.14 M(+13.0%) | -$5.81 M(+3.0%) | -$21.14 M(+4.3%) |
Sep 2023 | - | -$5.64 M(+6.1%) | -$20.27 M(+5.3%) |
Jun 2023 | - | -$5.32 M(+21.3%) | -$19.24 M(+3.4%) |
Mar 2023 | - | -$4.38 M(-11.2%) | -$18.61 M(-0.6%) |
Dec 2022 | -$18.71 M(+27.2%) | -$4.94 M(+7.1%) | -$18.71 M(+5.7%) |
Sep 2022 | - | -$4.61 M(-1.5%) | -$17.71 M(+3.4%) |
Jun 2022 | - | -$4.68 M(+4.3%) | -$17.13 M(+7.8%) |
Mar 2022 | - | -$4.49 M(+14.1%) | -$15.89 M(+8.0%) |
Dec 2021 | -$14.72 M(+41.8%) | -$3.93 M(-2.5%) | -$14.72 M(+1.5%) |
Sep 2021 | - | -$4.03 M(+17.2%) | -$14.50 M(+14.5%) |
Jun 2021 | - | -$3.44 M(+3.8%) | -$12.67 M(+8.5%) |
Mar 2021 | - | -$3.31 M(-10.9%) | -$11.67 M(+12.5%) |
Dec 2020 | -$10.38 M(+5.7%) | -$3.72 M(+69.4%) | -$10.38 M(+13.2%) |
Sep 2020 | - | -$2.19 M(-10.3%) | -$9.17 M(+2.2%) |
Jun 2020 | - | -$2.45 M(+21.0%) | -$8.97 M(+3.0%) |
Mar 2020 | - | -$2.02 M(-19.4%) | -$8.71 M(-11.3%) |
Dec 2019 | -$9.82 M(+29.0%) | -$2.51 M(+25.5%) | -$9.82 M(+3.2%) |
Sep 2019 | - | -$2.00 M(-8.5%) | -$9.52 M(+0.2%) |
Jun 2019 | - | -$2.18 M(-30.3%) | -$9.50 M(+8.1%) |
Mar 2019 | - | -$3.13 M(+41.9%) | -$8.79 M(+15.5%) |
Dec 2018 | -$7.61 M(-8.2%) | -$2.21 M(+11.5%) | -$7.61 M(+10.7%) |
Sep 2018 | - | -$1.98 M(+34.4%) | -$6.88 M(-1.5%) |
Jun 2018 | - | -$1.47 M(-24.6%) | -$6.99 M(-10.5%) |
Mar 2018 | - | -$1.95 M(+32.6%) | -$7.81 M(-5.9%) |
Dec 2017 | -$8.29 M(+7.1%) | -$1.47 M(-29.4%) | -$8.29 M(-7.1%) |
Sep 2017 | - | -$2.09 M(-9.1%) | -$8.93 M(+3.3%) |
Jun 2017 | - | -$2.29 M(-5.9%) | -$8.64 M(+6.6%) |
Mar 2017 | - | -$2.44 M(+15.5%) | -$8.11 M(+4.7%) |
Dec 2016 | -$7.74 M | -$2.11 M(+17.4%) | -$7.74 M(-6.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2016 | - | -$1.80 M(+2.3%) | -$8.27 M(-16.2%) |
Jun 2016 | - | -$1.76 M(-15.2%) | -$9.86 M(-15.9%) |
Mar 2016 | - | -$2.07 M(-21.4%) | -$11.72 M(-19.4%) |
Dec 2015 | -$14.54 M(-38.6%) | -$2.64 M(-22.3%) | -$14.54 M(-11.1%) |
Sep 2015 | - | -$3.39 M(-6.3%) | -$16.35 M(-15.7%) |
Jun 2015 | - | -$3.62 M(-26.0%) | -$19.39 M(-15.6%) |
Mar 2015 | - | -$4.89 M(+10.1%) | -$22.97 M(-3.0%) |
Dec 2014 | -$23.67 M(+161.5%) | -$4.44 M(-30.9%) | -$23.67 M(+23.1%) |
Sep 2014 | - | -$6.43 M(-10.7%) | -$19.23 M(+15.4%) |
Jun 2014 | - | -$7.20 M(+28.7%) | -$16.66 M(-29.4%) |
Mar 2014 | - | -$5.60 M(+44.8%) | -$23.59 M(-7.7%) |
Dec 2013 | -$9.05 M(-63.8%) | - | - |
Sep 2013 | - | -$3.87 M(-72.6%) | -$25.57 M(+2.3%) |
Jun 2013 | - | -$14.12 M(+339.9%) | -$24.99 M(+130.0%) |
Jun 2013 | -$24.98 M(+295.3%) | - | - |
Mar 2013 | - | -$3.21 M(-26.5%) | -$10.86 M(+0.8%) |
Dec 2012 | - | -$4.37 M(+32.9%) | -$10.78 M(-24.9%) |
Sep 2012 | - | -$3.29 M(+5.1%) | -$14.35 M(-6.7%) |
Jun 2012 | -$6.32 M(-53.0%) | - | - |
Mar 2012 | - | -$3.13 M(-60.6%) | -$15.39 M(+14.6%) |
Dec 2011 | -$13.43 M(>+9900.0%) | -$7.94 M(+269.3%) | -$13.43 M(+144.4%) |
Sep 2011 | - | -$2.15 M(-1.0%) | -$5.49 M(+64.5%) |
Jun 2011 | - | -$2.17 M(+85.6%) | -$3.34 M(+185.4%) |
Mar 2011 | - | -$1.17 M(>+9900.0%) | -$1.17 M(>+9900.0%) |
Dec 2010 | - | -$2600.00(-152.0%) | -$3800.00(-2.6%) |
Sep 2010 | - | $5000.00(-308.3%) | -$3900.00(+69.6%) |
Jun 2010 | -$15.50 K(+307.9%) | -$2400.00(-36.8%) | -$2300.00(+2200.0%) |
Mar 2010 | - | -$3800.00(+40.7%) | -$100.00(-102.8%) |
Dec 2009 | - | -$2700.00(-140.9%) | $3600.00(-42.9%) |
Sep 2009 | - | $6600.00(-3400.0%) | $6300.00(-2200.0%) |
Jun 2009 | -$3800.00 | -$200.00(+100.0%) | -$300.00(+200.0%) |
Mar 2009 | - | -$100.00 | -$100.00 |
FAQ
- What is InspireMD annual earnings before interest & taxes?
- What is the all time high annual EBIT for InspireMD?
- What is InspireMD annual EBIT year-on-year change?
- What is InspireMD quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for InspireMD?
- What is InspireMD quarterly EBIT year-on-year change?
- What is InspireMD TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for InspireMD?
- What is InspireMD TTM EBIT year-on-year change?
What is InspireMD annual earnings before interest & taxes?
The current annual EBIT of NSPR is -$21.14 M
What is the all time high annual EBIT for InspireMD?
InspireMD all-time high annual earnings before interest & taxes is -$3800.00
What is InspireMD annual EBIT year-on-year change?
Over the past year, NSPR annual earnings before interest & taxes has changed by -$2.43 M (-12.99%)
What is InspireMD quarterly earnings before interest & taxes?
The current quarterly EBIT of NSPR is -$8.46 M
What is the all time high quarterly EBIT for InspireMD?
InspireMD all-time high quarterly earnings before interest & taxes is $6600.00
What is InspireMD quarterly EBIT year-on-year change?
Over the past year, NSPR quarterly earnings before interest & taxes has changed by -$2.82 M (-50.06%)
What is InspireMD TTM earnings before interest & taxes?
The current TTM EBIT of NSPR is -$29.94 M
What is the all time high TTM EBIT for InspireMD?
InspireMD all-time high TTM earnings before interest & taxes is $6300.00
What is InspireMD TTM EBIT year-on-year change?
Over the past year, NSPR TTM earnings before interest & taxes has changed by -$9.67 M (-47.72%)